The briefing
Researchers at the University of Texas Medical Branch identified how the ATR enzyme safeguards DNA when cells replicate damaged genetic material. The insight could inform more precise development of cancer therapies that exploit DNA damage responses.
Original headline
New mechanism to enhance precision in cancer drug development